Kezar Life Sciences, Inc.

Nasdaq:KZR

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/25/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

39 shown

Filed	Period
11/12/25	Q4 FY2025	→
10/16/25	Q3 FY2025	→
8/13/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/25/25	Q1 FY2025	→
1/10/25	Q4 FY2025	→
↓

News (8-K)

41 shown

Filed	Type	Description
3/12/26	Acquisition	Entry into a Material Definitive Agreement	→
11/7/25	Other	Costs Associated with Exit or Disposal Activities	→
10/22/25	Other	Termination of a Material Definitive Agreement	→
6/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/1/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/27/25	Other	Other Events	→
↓

Prospectuses & Registrations

29 shown

Filed	Form	Description
4/25/25	ARS	ARS	→
3/25/25	S-8	S-8	→
2/5/25	S-3	S-3	→
4/26/24	ARS	ARS	→
3/22/24	424B5	424B5	→
3/14/24	S-8	S-8	→
↓

Filing History(446 filings)

TypeDateAccessionPeriodSize

8-K

Mar 12, 2026

0001628280-26-0170468-K

Mar 6, 2026

535.7 KB

SCHEDULE 13G/A

Feb 13, 2026

0000935836-26-000091

—

17.1 KB

SCHEDULE 13G/A

Feb 9, 2026

0001373604-26-000018

—

6.2 KB

SCHEDULE 13G/A

Nov 14, 2025

0000919574-25-006912

—

25.8 KB

10-Q

Nov 12, 2025

0001628280-25-05162310-Q

Sep 30, 2025

6.7 MB

8-K

Nov 12, 2025

0001628280-25-0515928-K

Nov 12, 2025

236.3 KB

8-K

Nov 7, 2025

0001628280-25-0506718-K

Nov 6, 2025

183.8 KB

8-K

Oct 22, 2025

0001628280-25-0458718-K

Oct 20, 2025

182.8 KB

8-K

Oct 16, 2025

0001628280-25-0452158-K

Oct 16, 2025

251.9 KB

SCHEDULE 13G

Sep 8, 2025

0000935836-25-000592

—

17.2 KB

10-Q

Aug 13, 2025

0001645666-25-00003710-Q

Jun 30, 2025

6.5 MB

8-K

Aug 13, 2025

0001645666-25-0000368-K

Aug 13, 2025

234.4 KB

Jul 3, 2025

0001415889-25-019311

Jul 2, 2025

5.0 KB

Jul 3, 2025

0001415889-25-019310

Jul 2, 2025

5.0 KB

Jul 1, 2025

0001415889-25-018733

Jul 1, 2025

5.5 KB

Jun 23, 2025

0001415889-25-017971

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017970

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017969

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017968

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017967

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017966

Jun 18, 2025

5.3 KB

Jun 23, 2025

0001415889-25-017965

Jun 18, 2025

5.4 KB

8-K

Jun 23, 2025

0001645666-25-0000298-K

Jun 17, 2025

149.3 KB

10-Q

May 13, 2025

0001645666-25-00002710-Q

Mar 31, 2025

6.1 MB

8-K

May 13, 2025

0001645666-25-0000268-K

May 13, 2025

197.8 KB

25 filings shown

Kezar Life Sciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(446 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/16/24	PRE 14A	PRE 14A	→
4/27/23	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
7/3/25	4	4	→
7/3/25	4	4	→
7/1/25	4	4	→
6/23/25	4	4	→
6/23/25	4	4	→
6/23/25	4	4	→
↓

Filed	Form	Description
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/8/25	SCHEDULE 13G	SCHEDULE 13G	→
3/21/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/6/25	SCHEDULE 13G	SCHEDULE 13G	→
↓